Hampton was appointed by the Justice Department in 2019 to represent the financial interests of victims in the Purdue Pharma bankruptcy case. For two years, he served on a committee of creditors.

When Purdue Pharma, the maker of OxyContin, declared bankruptcy in 2019, it had no debt and was worth more than a billion dollars. How is this possible? Well Purdue was facing trillions in claims ...

Purdue Pharma and owners to pay $7.4 billion in settlement of lawsuits over the toll of OxyContin Members of the family who own OxyContin maker Purdue Pharma, and the company itself, agreed to pay ...

Local governments began suing pharmaceutical companies such as Purdue Pharma in 2017. Brad Schimel was the state attorney general during that time frame, not working at the Waukesha County level.

The Purdue University Pharmacy is located in Room 118 of the Robert E. Heine Pharmacy Building — next to the Purdue University Student Health (PUSH) Center — so you don't ever need to leave campus.

Purdue Pharma’s owners from the Sackler family have struck a new $6.5 billion settlement of mass litigation alleging they fueled addiction, reopening a path to end the longest and costliest ...

Local governments began suing pharmaceutical companies such as Purdue Pharma in 2017. Brad Schimel was the state attorney general during that time frame, not working at the Waukesha County level.

Click to share on Facebook (Opens in new window) Click to share on X (Opens in new window) Click to email a link to a friend (Opens in new window) Click to share on LinkedIn (Opens in new window ...

The U.S. Supreme Court is hearing many important cases this term, but perhaps none are as consequential — or controversial — as one involving Purdue Pharma. The long-maligned pharmaceutical ...

Purdue Pharma, manufacturer of the highly addictive pain killer oxycontin, declared bankruptcy in 2019 and entered into a multibillion dollar settlement over their sales practices with the ...

M embers of the family who own OxyContin maker Purdue Pharma, and the company itself, agreed to pay up to $7.4 billion in a new settlement to lawsuits over the toll of the powerful prescription ...